Rezpegaldesleukin, an investigational interleukin-pathway agonist, demonstrated efficacy and safety for people with moderate ...

Rezpeg's promising Phase 2b data makes Nektar Therapeutics a strong contender in the AD market. Click here to read an ...

Gluten-stimulated interleukin-2 (IL-2) secretion is useful for diagnosis of celiac disease (CeD), according to a study published online.

The Nintendo Switch 2 launches on June 5 with a price tag of $449.99, making it a significant investment for any gaming setup. With nearly a year of anticipatio ...

New Publication Highlights Unique Properties of ATI-2138, a Potent and Selective Inhibitor of ITK and JAK3 Aclaris Therapeutics, Inc. Wed, Feb 12, 2025, 6:50 AM 5 min read ...

In a new study, researchers identify biomarkers that may predict the efficacy of low-dose IL-2 (Ld-IL2) treatment in people with systemic lupus erythematosus (SLE). IL-2 stands for interleukin-2 – a ...

Pembrolizumab did not affect WTX-124 or IL-2 PK. WTX-124 has been escalated to 12 mg IV Q2W, the initial monotherapy dose that produced objective responses, in combination with pembrolizumab.

IL-2-inducible T-cell kinase (ITK), a member of the Tec family of tyrosine kinases, is the predominant Tec kinase in T cells. Researchers have shown that ITK is involved in the pathogenesis of ...

Iovance Biotherapeutics Inc (NASDAQ: IOVA) has agreed to acquire worldwide rights to Proleukin (aldesleukin), an interleukin-2 (IL-2) product, from Clinigen Limited. Iovance expects the benefits ...

Arsenal eased to a 2-0 victory over Wolves in the Premier League at Molineux Stadium thanks to two goals from captain Martin Odegaard. Mikel Arteta's side enter the World Cup break with a five ...

We have focused on PD-1-IL-2 as a biology that has great potential for benefiting patients,” said John Mulligan, Ph.D., Founder and CEO of Good Therapeutics.

XTX202 is expected, therefore, to achieve a wider therapeutic index resulting in increased efficacy and lower toxicity compared to existing non-tumor selective IL-2 based-therapies. The IL-2 domain of ...